Tafolecimab (Anti-PCSK9)
Tafolecimab (Anti-PCSK9) is a human lgG2 monoclonal antibody that specifically targets PCSK-9. It may be used in studies of hypercholesterolaemia. MW :145.34 KD.
| Trivial name | IBI-306 |
| Catalog Number | A3067 |
| CAS# | 2225109-03-3 |
| Size | 1mg |